Indivior announces Graham Hetherington to its Board as Independent Director

– UK, Slough –  Indivior PLC (LON: INDV) today announced the appointment of Graham Hetherington as an Independent Non-Executive Director of the Company with effect from November 1, 2019. Graham will also be appointed as a member of the Audit Committee with effect from the same date.

“We are delighted to announce that Graham Hetherington has agreed to join the Board. Graham brings with him a strong track record of industry and financial experience having served as the Chief Financial Officer of two FTSE 100 companies.” said, Howard Pien, Chair.

About Graham Hetherington

Graham was Chair of the Audit Committee of BTG plc from 2016 and Senior Independent Director from 2017 until its acquisition by Boston Scientific Corporation in August 2019. He was previously Chief Financial Officer of Shire PLC, a global pharmaceutical company with a market capitalisation of over £33bn, from 2008 until 2014, Chief Financial Officer of Bacardi and Company between 2007-08 and Chief Financial Officer of Allied Domecq plc from 1999 to 2005. He is a Fellow of the Chartered Institute of Management Accountants.

Until recently, Graham was Senior Independent Director and Chair of the Audit Committee of BTG plc, a global healthcare company.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.